Kevin McElgunn
Corporate Officer/Principal bei MYERS INDUSTRIES, INC.
Aktive Positionen von Kevin McElgunn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MYERS INDUSTRIES, INC. | Corporate Officer/Principal | 01.06.2022 | - |
Karriereverlauf von Kevin McElgunn
Ehemalige bekannte Positionen von Kevin McElgunn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Dow Chemical Corporate Venture Capital
 Dow Chemical Corporate Venture Capital Investment ManagersFinance Dow Chemical Corporate Venture Capital (DCCVC) is a venture capital firm subsidiary of Dow Chemical Co. (NYSE:DOW) founded in 1994. The firm is headquartered in Midland, Michigan. | Private Equity Investor | 08.02.2011 | 01.03.2018 |
| PFENEX INC. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Kevin McElgunn
| Kansas State University | Undergraduate Degree |
| Northwood University (Michigan) | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MYERS INDUSTRIES, INC. | Producer Manufacturing |
| Private Unternehmen | 2 |
|---|---|
Dow Chemical Corporate Venture Capital
Dow Chemical Corporate Venture Capital Investment ManagersFinance Dow Chemical Corporate Venture Capital (DCCVC) is a venture capital firm subsidiary of Dow Chemical Co. (NYSE:DOW) founded in 1994. The firm is headquartered in Midland, Michigan. | Finance |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Kevin McElgunn
- Erfahrung
